Compare SIDU & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIDU | GNTA |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.7M | 34.0M |
| IPO Year | 2021 | N/A |
| Metric | SIDU | GNTA |
|---|---|---|
| Price | $1.99 | $0.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 59.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 84.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,672,646.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $0.71 |
| 52 Week High | $5.39 | $10.00 |
| Indicator | SIDU | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 42.82 |
| Support Level | $1.80 | $0.71 |
| Resistance Level | $2.19 | $1.70 |
| Average True Range (ATR) | 0.18 | 0.09 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 39.13 | 31.33 |
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.